Pilot RCT and Interview Study on an HIV Chatbot in Nigeria

Last updated: January 22, 2026
Sponsor: Christoph Pimmer
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Hiv

Treatment

Chatbot as an informational coach

Clinical Study ID

NCT06814041
IZSTZ0_202602
  • Ages > 18
  • All Genders

Study Summary

This study will investigate the use of a HIV chatbot that acts as an informational coach.

The main question the study aims to answer is:

Does the chatbot improve HIV knowledge in adults (older than 18-years) newly diagnosed with HIV in Nigeria - compared to a control group?

Moreover, the study will also determine potential effects of the chatbot use on patients' resilience, psychological well-being. The study will explore patients' use and perceptions of the chatbot, as well as potential gender differences.

The control group will receive Standard of Care only. Patients in the chatbot intervention group will interact with the chatbot in addition to receiving Standard of Care. They will be able to:

  • Use a chatbot via WhatsApp

  • Receive information on relevant HIV topics

  • Get automated responses to their HIV-related questions

  • Be reminded of medical appointments and medication schedules

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with HIV

  • ART enrollment: at the day of recruitment or in the subsequent 7 days. But no longerthan 30 months prior to enrolment in the study..

  • Age ≥ 18 years

  • Have a personal internet-enabled smartphone with WhatsApp installed

  • Carry the phone with them at the time of recruitment

  • Able to understand, read, and write in English (the official language in Nigeria)

  • Able to understand the information about the study

  • Provide written informed consent.

Exclusion

Exclusion Criteria:

  • Known pregnancy or ≤3 months postpartum

  • Persons with suicidal ideation and/or severe mental distress

Study Design

Total Participants: 314
Treatment Group(s): 1
Primary Treatment: Chatbot as an informational coach
Phase:
Study Start date:
April 14, 2025
Estimated Completion Date:
June 20, 2026

Connect with a study center

  • Infectious Disease Institute, (IDI) UCH

    Ibadan, Oyo
    Nigeria

    Active - Recruiting

  • Baptist Medical Centre

    Saki, Oyo
    Nigeria

    Site Not Available

  • Infectious Disease Institute, (IDI) UCH

    Ibadan 2339354, Oyo State 2325190
    Nigeria

    Site Not Available

  • St. Mary's Catholic General Hospital

    Ibadan 2339354, Oyo State 2325190
    Nigeria

    Site Not Available

  • Baptist Medical Centre

    Saki 2323390, Oyo State 2325190
    Nigeria

    Site Not Available

  • Adeoyo Maternity Teaching Hospital

    Ibadan, Oyo
    Nigeria

    Site Not Available

  • Adeoyo Maternity Teaching Hospital

    Ibadan 2339354, Oyo
    Nigeria

    Site Not Available

  • Our Lady of Apostle Catholic Hospital

    Ibadan 2339354,
    Nigeria

    Site Not Available

  • Ring Road State Hospital

    Ibadan 2339354,
    Nigeria

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.